Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group

29Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In drug discovery, structural modifications over the lead molecule are often crucial for the development of a drug. Herein, we reported the first in vivo bioisosteric effect of phosphinolactone function in relation to the lactol group constituting the bioactive molecule: Hydroxybupropion. The preparation of phosphinolactone analogues and their antidepressant evaluation towards forced swimming test in mice showed that biological activity was regained and even strengthen. © 2010 The Royal Society of Chemistry.

Cite

CITATION STYLE

APA

Volle, J. N., Filippini, D., Krawczy, B., Kaloyanov, N., Van Der Lee, A., Maurice, T., … Virieux, D. (2010). Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group. Organic and Biomolecular Chemistry, 8(6), 1438–1444. https://doi.org/10.1039/b919345f

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free